Literature DB >> 11578065

Genetic mutations in exons 3 and 4 of the pancreatic secretory trypsin inhibitor in patients with pancreatitis.

K Kuwata1, M Hirota, H Sugita, M Kai, N Hayashi, M Nakamura, T Matsuura, N Adachi, I Nishimori, M Ogawa.   

Abstract

PURPOSE: We hypothesized that mutations in the pancreatic secretory trypsin inhibitor (PSTI) gene could promote autodigestion, leading to acute or chronic pancreatitis. Our investigation involved mutation analysis of the PSTI gene in patients with acute or chronic pancreatitis.
METHODS: Mutation analysis for the PSTI gene was performed in patients with acute or chronic pancreatitis. Unrelated healthy volunteers and family members of a chronic pancreatitis patient with point mutations in the PSTI gene were also analyzed.
RESULTS: Two types of single-point mutation in the PSTI gene were observed in one patient with chronic pancreatitis: 34Asn (AAT)-to-Ser (AGT) (101 A > G N34S: N34S) in exon 3, and 67Arg (CGC)-to-Cys (TGC) (199 C > T R67C: R67C) in exon 4. No mutations with amino-acid substitution were found in other patients or in the volunteer group. In the patient with the PSTI gene mutations, no additional mutations were observed in the cationic trypsinogen gene. The family study revealed that the mother and a maternal uncle were homozygotes for the N34S mutation, while the father and brother were compound heterozygotes for the N34S and R67C mutations. The uncle (N34S/N34S) showed clinical manifestations of pancreatitis, but the other family members did not.
CONCLUSIONS: The N34S mutation may cause a predisposition to pancreatitis, with incomplete penetrance. However, with the limited information available, it is not known whether the R67C mutation promotes pancreatitis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11578065     DOI: 10.1007/s005350170045

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   7.527


  11 in total

Review 1.  The role of trypsin, trypsin inhibitor, and trypsin receptor in the onset and aggravation of pancreatitis.

Authors:  Masahiko Hirota; Masaki Ohmuraya; Hideo Baba
Journal:  J Gastroenterol       Date:  2006-09       Impact factor: 7.527

Review 2.  Genetics of acute and chronic pancreatitis: An update.

Authors:  Vv Ravi Kanth; D Nageshwar Reddy
Journal:  World J Gastrointest Pathophysiol       Date:  2014-11-15

Review 3.  Genetic background of pancreatitis.

Authors:  Masahiko Hirota; Masaki Ohmuraya; Hideo Baba
Journal:  Postgrad Med J       Date:  2006-12       Impact factor: 2.401

Review 4.  Pathophysiology of alcoholic pancreatitis: an overview.

Authors:  Parimal Chowdhury; Priya Gupta
Journal:  World J Gastroenterol       Date:  2006-12-14       Impact factor: 5.742

5.  Limited contribution of the SPINK1 N34S mutation to the risk and severity of alcoholic chronic pancreatitis: a report from the United States.

Authors:  Alexander Schneider; Roland H Pfützer; M Michael Barmada; Adam Slivka; John Martin; David C Whitcomb
Journal:  Dig Dis Sci       Date:  2003-06       Impact factor: 3.199

6.  PRSS1 and SPINK1 mutations in idiopathic chronic and recurrent acute pancreatitis.

Authors:  Mario Pelaez-Luna; Guillermo Robles-Diaz; Samuel Canizales-Quinteros; Maria T Tusié-Luna
Journal:  World J Gastroenterol       Date:  2014-09-07       Impact factor: 5.742

7.  Missense mutations in pancreatic secretory trypsin inhibitor (SPINK1) cause intracellular retention and degradation.

Authors:  Orsolya Király; Thomas Wartmann; Miklós Sahin-Tóth
Journal:  Gut       Date:  2007-05-24       Impact factor: 23.059

Review 8.  Chronic pancreatitis and cystic fibrosis.

Authors:  H Witt
Journal:  Gut       Date:  2003-05       Impact factor: 23.059

9.  Molecular dynamics simulations reveal structural instability of human trypsin inhibitor upon D50E and Y54H mutations.

Authors:  Wanwimon Mokmak; Surasak Chunsrivirot; Anunchai Assawamakin; Kiattawee Choowongkomon; Sissades Tongsima
Journal:  J Mol Model       Date:  2012-09-07       Impact factor: 1.810

10.  The prevalence of cationic trypsinogen (PRSS1) and serine protease inhibitor, Kazal type 1 (SPINK1) gene mutations in Polish patients with alcoholic and idiopathic chronic pancreatitis.

Authors:  Anita Gasiorowska; Renata Talar-Wojnarowska; Leszek Czupryniak; Beata Smolarz; Hanna Romanowicz-Makowska; Andrzej Kulig; Ewa Malecka-Panas
Journal:  Dig Dis Sci       Date:  2010-07-30       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.